These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported Terminated||2006-001846-15||A placebo-controlled, randomised, double-blind, single dose proof of concept study of Kappaproct, in steroid resistant or steroid dependent patients with ulcerative colitis of mild to moderate degree||2009-04-15||due-trials|
|Not reported Terminated||2009-010756-10||Effect of an additional single dose of Kappaproct to corticosteroid treated patients with brain edema caused by brain tumor||2011-05-27||due-trials|
|Listed as ongoing, but also has a completion date||2011-003130-14||A placebo-controlled, double-blind, randomised study to assess the efficacy and safety of Kappaproct as an add-on to current practice in chronic active treatment refractory ulcerative colitis patients||2014-04-30||bad-data|
|Ongoing||2016-004217-26||A Randomised Dose-Optimisation Study to Evaluate the Efficacy and Safety of Cobitolimod in Moderate to Severe Active Ulcerative Colitis Patients||not-yet-due|